In addition, the survival analysis revealed that a high expression of MICB mRNA was significantly associated with poor PFS in ovarian cancer patients, including ovarian serous carcinoma and ovarian endometrioid adenocarcinoma patients, which was also similar with SFN’ survival analysis in ovarian cancer. The gene discussed is MICB; the disease is ovarian carcinoma.